Skip to main content
. 2012 Apr 5;2012:275624. doi: 10.1155/2012/275624

Table 2.

Study quality summary.

First author (Ref) Clear identification of study population Clear definition of outcome and outcome assessment Independent Assessment of outcome parameters No selective loss during followup Important confounders and/or prognostic factors indentified Adjusted odds ratio
(specific adjusters)
Marcus et al. [7] Yes Yes Yes Yes Yes 0.75
(age, gender)
Go et al. [16] Yes Yes Yes Yes Yes Not provided
Alonso et al. [17] Yes Yes Yes Yes Yes 0.59
(age, gender)
Afzal et al. [18] Yes Yes No Yes Yes Not provided
Ruo et al. [19] Yes Yes Yes Yes Yes 0.51
(age, gender, Comorbid conditions, medications)
Winkelmayer et al. [20] Yes Yes Yes Yes Yes Not provided
Upshaw Jr. [21] Yes Yes Yes Yes Yes Not provided
Shen et al. [22] Yes Yes Yes Yes Yes 0.49
(age, gender)
Smith et al. [23] Yes Yes Yes Yes Yes 0.64 (unclear)
Lahiri et al. [24] Yes Yes Yes Yes Yes 0.54
(age, gender, comorbid conditions)